Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Anika Therapeutics Inc. (NASDAQ: ANIK).

Full DD Report for ANIK

You must become a subscriber to view this report.


Recent News from (NASDAQ: ANIK)

Anika to Showcase Commercial and Pipeline Portfolio at 18th Bi-Annual European Society for Sports Traumatology, Knee Surgery and Arthroscopy Congress
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology , today announced plans to showcase its innovative commercial and pipeline port...
Source: Business Wire
Date: May, 08 2018 16:05
Your Daily Pharma Scoop: Synergy Activism, Pfizer Wave Sciences Collaboration, Agenus Update
Analysis focus: SGYP Synergy Pharma (SGYP), ever the laggard, and the bane of many a portfolio, suddenly saw a bit of movement yesterday on the back of news that a group of activist investor s have taken up the cudgel against the management of Synergy. These investors have written to a nu...
Source: SeekingAlpha
Date: May, 08 2018 03:34
Your Daily Pharma Scoop: Alnylam Update, Malinckrodt's Adcom Failure, Anika's Drug Recall
Analysis focus: ALNY Alnylam (ALNY), a leading RNAi therapeutics company, reported earnings last week. It beat on EPS, which at -$1.22 beat by $0.25. However, its revenue , despite rising 15% y/y, stood at $21.9mn, $8.25mn short of consensus. So, the company must have managed to cut costs...
Source: SeekingAlpha
Date: May, 07 2018 08:00
Anika Therapeutics Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Anika Therapeutics Inc. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 04 2018 14:00
Anika Therapeutics Inc. (ANIK) CEO Joseph Darling on Q1 2018 Results - Earnings Call Transcript
Anika Therapeutics Inc. (ANIK) Q1 2018 Earnings Conference Call May 3, 2018 09:00 a.m. ET Executives Joseph Darling - President, Chief Executive Officer Sylvia Cheung - Chief Financial Officer Analysts Joe Munda - First Analysis Lisa Springer - Singular Research Jim Sidot...
Source: SeekingAlpha
Date: May, 03 2018 15:14
Midday Gainers / Losers (05/03/2018)
Gainers:  VVPR +179% . CLWT +71% . IMTE +55% . OTCQB:MKGI +40% . SEII +28% . AMRH +25% . STAA +26% . AMDA +22% . BOXL +20% . NDRA +18% . More news on: VivoPower International PLC, Euro Tech Holdings Company Limited, Integrated Media Technology Limited, ...
Source: SeekingAlpha
Date: May, 03 2018 12:40
Anika down 28% on Q1 miss and product recall
Thinly traded small cap Anika Therapeutics ( ANIK -28.1% ) slumps on double normal volume, albeit on turnover of only ~250K shares, after it released Q1 results after the close yesterday. More news on: Anika Therapeutics Inc., Healthcare stocks news, Earnings news and commentary, Stock...
Source: SeekingAlpha
Date: May, 03 2018 11:33
Anika Therapeutics EPS of -$0.46
Anika Therapeutics (NASDAQ: ANIK ): Q1 EPS of -$0.46 may not be comparable to consensus of $0.16. More news on: Anika Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 02 2018 16:21
Anika Reports First Quarter 2018 Financial Results
Successful Leadership Transition in Evolution to a Global Commercial Organization; MONOVISC and CINGAL Global Revenue Increased 38% Year-over-Year; Initiated Voluntary Recall of HYALOFAST, HYALOGRAFT-C and HYALOMATRIX Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integra...
Source: Business Wire
Date: May, 02 2018 16:05
Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical - Future Expectations, Projections Moving into 2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AMC Networks Inc. (NASDAQ:AMCX), JELD-WEN Holding, Inc. (NYSE:JELD), Bluep...
Source: GlobeNewswire
Date: May, 01 2018 07:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1739.6339.0340.6238.94162,530
2017-06-2047.2947.3347.7344.01119,213
2017-06-1945.4847.3147.6245.35248,973
2017-06-1645.4445.3246.1644.95153,693
2017-06-1546.5645.7946.7945.659788,597

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1511,26318,40461.1987Short
2018-08-149,77423,45241.6766Short
2018-08-133,67211,85530.9743Cover
2018-08-108,67118,64646.5033Short
2018-08-096,58620,68831.8349Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ANIK.


About Anika Therapeutics Inc. (NASDAQ: ANIK)

Logo for Anika Therapeutics Inc. (NASDAQ: ANIK)

Not available

 

Contact Information

 

 

Current Management

  • Douglas R. Potter / CEO, CFO

Current Share Structure

  • Market Cap: $558,075,385 - 05/14/2018
  • Issue and Outstanding: 14,693,928 - 02/09/2018

 


Recent Filings from (NASDAQ: ANIK)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 17 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 17 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 06 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 21 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018

 

 


Daily Technical Chart for (NASDAQ: ANIK)

Daily Technical Chart for (NASDAQ: ANIK)


Stay tuned for daily updates and more on (NASDAQ: ANIK)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ANIK)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ANIK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ANIK and does not buy, sell, or trade any shares of ANIK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/